No Data
No Data
ImmunoPrecise Antibodies Advances Therapeutic Innovation With Rabbit Antibody Developments, Says Rabbit B Cell Select Drives Clinical Breakthroughs In Cancer Treatment
Express News | Immunoprecise Antibodies Advances Therapeutic Innovation With Groundbreaking Rabbit Antibody Developments
Press Release: Institute for Portfolio Alternatives Announces 2025 Board of Directors
ImmunoPrecise Antibodies Price Target Maintained With a $9.00/Share by HC Wainwright & Co.
ImmunoPrecise Antibodies Analyst Ratings
Maintained Buy Rating for ImmunoPrecise Antibodies on Strong Revenue and Strategic Growth Prospects